Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1). (Q42329441)
Jump to navigation
Jump to search
scientific article published on 16 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1). |
scientific article published on 16 January 2016 |
Statements
1 reference
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1). (English)
1 reference
E Franek
1 reference
I B Hirsch
1 reference
H Mersebach
1 reference
L Bardtrum
1 reference
K Hermansen
1 reference
16 January 2016
1 reference
1 reference
167-173
1 reference
Identifiers
1 reference
1 reference
1 reference